Cell and gene therapy in Australia

Martiniello-Wilks, R; Rasko, JEJ

Cell and gene therapy in Australia

Martiniello-Wilks, R

Rasko, JEJ

Permalink

Publication Type:: Journal Article
Citation:: Cytotherapy, 2007, 9 (3), pp. 209 - 221
Issue Date:: 2007-01-01

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download full textAdobe PDF (63.16 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Martiniello-Wilks, R https://orcid.org/0000-0002-0038-3430	en_US
dc.contributor.author	Rasko, JEJ	en_US
dc.date.issued	2007-01-01	en_US
dc.identifier.citation	Cytotherapy, 2007, 9 (3), pp. 209 - 221	en_US
dc.identifier.issn	1465-3249	en_US
dc.identifier.uri	http://hdl.handle.net/10453/15538
dc.description.abstract	The expansion of human cells to produce cell therapeutic products for the treatment of disease is, with few exceptions, an experimental therapy. Because cell therapies involve a biological product, often with some genetic or other modification, they require extensive pre-clinical research and development. Cell therapy production processes and premises require licensing by the Therapeutic Goods Administration. In this review, timed to coincide with the international meetings of the ISCT and ISSCR in Australia, we describe some promising cell therapies currently under development.	en_US
dc.relation.ispartof	Cytotherapy	en_US
dc.relation.isbasedon	10.1080/14653240701292297	en_US
dc.subject.classification	Immunology	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Vaccines	en_US
dc.subject.mesh	Gene Therapy	en_US
dc.subject.mesh	Immunotherapy	en_US
dc.subject.mesh	Cell Transplantation	en_US
dc.subject.mesh	Regeneration	en_US
dc.subject.mesh	Australia	en_US
dc.subject.mesh	Clinical Trials as Topic	en_US
dc.subject.mesh	Genetic Therapy	en_US
dc.title	Cell and gene therapy in Australia	en_US
dc.type	Journal Article
utslib.citation.volume	3	en_US
utslib.citation.volume	9	en_US
utslib.for	1103 Clinical Sciences	en_US
dc.location.activity	ISI:000246363700002	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Life Sciences
pubs.organisational-group	/University of Technology Sydney/Strength - CHT - Health Technologies
utslib.copyright.status	open_access
pubs.issue	3	en_US
pubs.publication-status	Published	en_US
pubs.volume	9	en_US

Abstract:

The expansion of human cells to produce cell therapeutic products for the treatment of disease is, with few exceptions, an experimental therapy. Because cell therapies involve a biological product, often with some genetic or other modification, they require extensive pre-clinical research and development. Cell therapy production processes and premises require licensing by the Therapeutic Goods Administration. In this review, timed to coincide with the international meetings of the ISCT and ISSCR in Australia, we describe some promising cell therapies currently under development.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/15538